Substance / Medication

Bacitracin A

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

3 trials linked to this intervention

3
Total Trials
1
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Isolation and detection of bacterial species on mitis salivarius bacitracin agar from the plaque samples of caries active children.
Bansal Kalpana, Shamoo Azeema, Atif Mohammad et al. · J Indian Soc Pedod Prev Dent · 2024
PMID: 38616422RCT
Effect of zinc bacitracin and phytase on growth performance, nutrient digestibility, carcass and meat traits of broilers.
Attia Y A, Bovera F, Abd El-Hamid A E et al. · J Anim Physiol Anim Nutr (Berl) · 2016
PMID: 26608478RCT
A novel selective medium Sucrose-Bacitracin agar 10 for accurate isolation and identification of Streptococcus mutans.
Fang Yuwen, Ma Qizhao, Zhao Wei et al. · BMC Oral Health · 2025
PMID: 40819078ObservationalFull text (PMC)
Validation of a quantitative HPLC method for bacitracin and bacitracin zinc using EDTA as a mobile-phase modifier.
Potts Alan R, Psurek Tatiana, Jones Cassandra et al. · J Pharm Biomed Anal · 2012
PMID: 22795823Observational
Collaborative study of a microbiological screening method (three-plate) for the banned antimicrobial growth promotors tylosin, virginiamycin, spiramycin, zinc bacitracin and avoparcin in animal feed.
Pol-Hofstad I, Driessen-Van Lankveld W, Tomassen M et al. · Food Addit Contam Part A Chem Anal Control Expo Risk Assess · 2008
PMID: 19680856Observational
Comparison of a Novel Silicone Gel Wound Dressing vs Bacitracin After Follicular Unit Extraction Hair Transplantation.
James Isaac B, Turer David M, DiBernardo Barry E · Aesthet Surg J Open Forum · 2022
PMID: 35072072Case ReportFull text (PMC)
Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test.
Uyar Belkız, Acar Emine Müge · Ann Dermatol · 2020
PMID: 33911761Case ReportFull text (PMC)
The extracellular domain ofNSrFP binds bacitracin and allows the identification of new members of the BceAB transporter family.
Mammen Christian, Gottstein Julia, Cea Pablo et al. · Front Microbiol · 2025
PMID: 41040882OtherFull text (PMC)
Bacitracin agar vs. oleandomycin disk supplemented chocolate agar for the recovery of Haemophilus influenzae in diagnostic samples: A prospective comparison.
Forstner Patrick, Laireiter Christina Maria, Friedl Simone et al. · Diagn Microbiol Infect Dis · 2024
PMID: 38422664Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bacitracin A (substance)
SNOMED CT
27736001
UMLS CUI
C0052882

Clinical Data

This intervention maps to 11 entities in the Healos knowledge graph.

6
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.